Establishes framework for regenerative medicine and cell-based therapies in New York, creating patient protections and disclosure requirements.

The bill establishes the "New York regenerative medicine advancement and patient protection act." It creates a framework for regenerative medicine and cell-based therapies, including patient protections and disclosure requirements. It authorizes limited physician use of qualifying regenerative medicine protocols, establishes a regenerative medicine registry, and creates the New York regenerative medicine innovation program. The bill also includes provisions for informed consent, advertising standards, and material adverse event reporting.

Establishes framework for regenerative medicine and cell-based therapies in New York, creating patient protections and disclosure requirements.

The bill establishes the "New York regenerative medicine advancement and patient protection act." It creates a framework for regenerative medicine and cell-based therapies, including patient protections and disclosure requirements. It authorizes limited physician use of qualifying regenerative medicine protocols, establishes a regenerative medicine registry, and creates the New York regenerative medicine innovation program. The bill also includes provisions for informed consent, advertising standards, and material adverse event reporting.